drugset / Trial / NCT03610230
Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients
RandomizedCrossoverOpen-labelTreatment
Summary
1. To compare patient-reported satisfaction, efficacy and short-term safety profile of Monofer® in a single bolus dose with Venofer® in split doses in the treatment of absolute or functional iron deficiency anemia in patients on PD. 2. To compare patient symptomatology on fatigue after treatment of Monofer® compared with Venofer® .
Timeline
- Start
- 2019-02-01
- Primary completion
- 2021-03-30
- Completion
- 2021-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iron isomaltoside 1000 | Unknown | 1000 mg | Intravenous |
| Subject | Iron sucrose | Unknown | 200 mg | Intravenous |